{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:55:56Z","timestamp":1788951356882,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS085880"],"award-info":[{"award-number":["R01 NS085880"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Huntington\u2019s disease (HD) is an incurable neurodegenerative disorder caused by CAG trinucleotide expansions in the\n                    <jats:italic>huntingtin<\/jats:italic>\n                    gene. Markers of both systemic and CNS immune activation and inflammation have been widely noted in HD and mouse models of HD. In particular, elevation of the pro-inflammatory cytokine interleukin-6 (IL-6) is the earliest reported marker of immune activation in HD, and this elevation has been suggested to contribute to HD pathogenesis. To test the hypothesis that IL-6 deficiency would be protective against the effects of mutant\n                    <jats:italic>huntingtin<\/jats:italic>\n                    , we generated R6\/2 HD model mice that lacked IL-6. Contrary to our prediction, IL-6 deficiency exacerbated HD-model associated behavioral phenotypes. Single nuclear RNA Sequencing (snRNA-seq) analysis of striatal cell types revealed that IL-6 deficiency led to the dysregulation of various genes associated with synaptic function, as well as the BDNF receptor\n                    <jats:italic>Ntrk2<\/jats:italic>\n                    . These data suggest that IL-6 deficiency exacerbates the effects of mutant\n                    <jats:italic>huntingtin<\/jats:italic>\n                    through dysregulation of genes of known relevance to HD pathobiology in striatal neurons, and further suggest that modulation of IL-6 to a level that promotes proper regulation of genes associated with synaptic function may hold promise as an HD therapeutic target.\n                  <\/jats:p>","DOI":"10.1186\/s13024-020-00379-3","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T08:02:40Z","timestamp":1590307360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Interleukin-6 deficiency exacerbates Huntington\u2019s disease model phenotypes"],"prefix":"10.1186","volume":"15","author":[{"given":"Mary H.","family":"Wertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Sebastian","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeseung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Kulicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manolis","family":"Kellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Heiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,24]]},"reference":[{"issue":"7","key":"379_CR1","doi-asserted-by":"publisher","first-page":"a024240","DOI":"10.1101\/cshperspect.a024240","volume":"7","author":"Maria Jimenez-Sanchez","year":"2016","unstructured":"Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC. Huntington's disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harbor perspectives in medicine. 2017;7.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"379_CR2","first-page":"60","volume":"7","author":"A Neueder","year":"2014","unstructured":"Neueder A, Bates GP. A common gene expression signature in Huntington's disease patient brain regions. BMC Med Genet. 2014;7:60.","journal-title":"BMC Med Genet"},{"key":"379_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1515\/CCLM.1998.132","volume":"36","author":"F Leblhuber","year":"1998","unstructured":"Leblhuber F, Walli J, Jellinger K, Tilz GP, Widner B, Laccone F, Fuchs D. Activated immune system in patients with Huntington's disease. Clin Chem Lab Med. 1998;36:747\u201350.","journal-title":"Clin Chem Lab Med"},{"key":"379_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143563","volume":"10","author":"A Labadorf","year":"2015","unstructured":"Labadorf A, Hoss AG, Lagomarsino V, Latourelle JC, Hadzi TC, Bregu J, MacDonald ME, Gusella JF, Chen JF, Akbarian S, et al. RNA sequence analysis of human Huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression. PLoS One. 2015;10:e0143563.","journal-title":"PLoS One"},{"key":"379_CR5","doi-asserted-by":"publisher","first-page":"44849","DOI":"10.1038\/srep44849","volume":"7","author":"DJ Hensman Moss","year":"2017","unstructured":"Hensman Moss DJ, Flower MD, Lo KK. Miller JR, van Ommen GB, t Hoen PA, stone TC, Guinee a, Langbehn DR, Jones L, et al: Huntington's disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer's disease. Sci Rep. 2017;7:44849.","journal-title":"Sci Rep"},{"key":"379_CR6","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1021\/pr0700753","volume":"6","author":"A Dalrymple","year":"2007","unstructured":"Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Bjorkqvist M, Petersen A, Jackson GS, Isaacs JD, Kristiansen M, Bates GP, et al. Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res. 2007;6:2833\u201340.","journal-title":"J Proteome Res"},{"key":"379_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, et al. Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet. 2006;15:965\u201377.","journal-title":"Hum Mol Genet"},{"key":"379_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1231","volume":"3","author":"E Wild","year":"2011","unstructured":"Wild E, Magnusson A, Lahiri N, Krus U, Orth M, Tabrizi SJ, Bjorkqvist M. Abnormal peripheral chemokine profile in Huntington's disease. PLoS currents. 2011;3:RRN1231.","journal-title":"PLoS currents"},{"key":"379_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","volume":"44","author":"KH Chang","year":"2015","unstructured":"Chang KH, Wu YR, Chen YC, Chen CM. Plasma inflammatory biomarkers for Huntington's disease patients and mouse model. Brain Behav Immun. 2015;44:121\u20137.","journal-title":"Brain Behav Immun"},{"key":"379_CR10","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bjorkqvist","year":"2008","unstructured":"Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D, et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J Exp Med. 2008;205:1869\u201377.","journal-title":"J Exp Med"},{"key":"379_CR11","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","volume":"24","author":"A Khoshnan","year":"2004","unstructured":"Khoshnan A, Ko J, Watkin EE, Paige LA, Reinhart PH, Patterson PH. Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. J Neurosci. 2004;24:7999\u20138008.","journal-title":"J Neurosci"},{"key":"379_CR12","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1128\/MCB.10.5.2327","volume":"10","author":"TA Libermann","year":"1990","unstructured":"Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol. 1990;10:2327\u201334.","journal-title":"Mol Cell Biol"},{"key":"379_CR13","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1046\/j.0953-816x.2001.01802.x","volume":"14","author":"JC Bensadoun","year":"2001","unstructured":"Bensadoun JC, de Almeida LP, Dreano M, Aebischer P, Deglon N. Neuroprotective effect of interleukin-6 and IL6\/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome. Eur J Neurosci. 2001;14:1753\u201361.","journal-title":"Eur J Neurosci"},{"key":"379_CR14","doi-asserted-by":"publisher","first-page":"18259","DOI":"10.1523\/JNEUROSCI.4008-12.2012","volume":"32","author":"J Bouchard","year":"2012","unstructured":"Bouchard J, Truong J, Bouchard K, Dunkelberger D, Desrayaud S, Moussaoui S, Tabrizi SJ, Stella N, Muchowski PJ. Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease. J Neurosci. 2012;32:18259\u201368.","journal-title":"J Neurosci"},{"key":"379_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87:493\u2013506.","journal-title":"Cell"},{"key":"379_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/368339a0","volume":"368","author":"M Kopf","year":"1994","unstructured":"Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994;368:339\u201342.","journal-title":"Nature"},{"key":"379_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbr.2003.12.018","volume":"153","author":"D Braida","year":"2004","unstructured":"Braida D, Sacerdote P, Panerai AE, Bianchi M, Aloisi AM, Iosue S, Sala M. Cognitive function in young and adult IL (interleukin)-6 deficient mice. Behav Brain Res. 2004;153:423\u20139.","journal-title":"Behav Brain Res"},{"key":"379_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm0102-75","volume":"8","author":"V Wallenius","year":"2002","unstructured":"Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med. 2002;8:75\u20139.","journal-title":"Nat Med"},{"key":"379_CR19","unstructured":"Mohammadi S, Davila-Velderrain J, Kellis M: Multi-resolution single-cell state characterization via joint archetypal\/network analysis. bioRxiv 2019."},{"key":"379_CR20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2018.07.028","volume":"174","author":"A Saunders","year":"2018","unstructured":"Saunders A, Macosko EZ, Wysoker A, Goldman M, Krienen FM, de Rivera H, Bien E, Baum M, Bortolin L, Wang S, et al. Molecular diversity and specializations among the cells of the adult mouse brain. Cell. 2018;174:1015\u201330 e1016.","journal-title":"Cell"},{"key":"379_CR21","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1016\/j.celrep.2019.11.096","volume":"29","author":"A Martin","year":"2019","unstructured":"Martin A, Calvigioni D, Tzortzi O, Fuzik J, Warnberg E, Meletis K. A Spatiomolecular map of the striatum. Cell Rep. 2019;29:4320\u201333 e4325.","journal-title":"Cell Rep"},{"key":"379_CR22","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","volume":"26","author":"A Lachmann","year":"2010","unstructured":"Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, Ma'ayan A. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics. 2010;26:2438\u201344.","journal-title":"Bioinformatics"},{"key":"379_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/science.8140422","volume":"264","author":"Z Zhong","year":"1994","unstructured":"Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994;264:95\u20138.","journal-title":"Science"},{"key":"379_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.neuron.2011.11.024","volume":"73","author":"CS Nicolas","year":"2012","unstructured":"Nicolas CS, Peineau S, Amici M, Csaba Z, Fafouri A, Javalet C, Collett VJ, Hildebrandt L, Seaton G, Choi SL, et al. The Jak\/STAT pathway is involved in synaptic plasticity. Neuron. 2012;73:374\u201390.","journal-title":"Neuron"},{"key":"379_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","volume":"5","author":"C Zuccato","year":"2009","unstructured":"Zuccato C, Cattaneo E. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol. 2009;5:311\u201322.","journal-title":"Nat Rev Neurol"},{"key":"379_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","volume":"33","author":"JL Plotkin","year":"2015","unstructured":"Plotkin JL, Surmeier DJ. Corticostriatal synaptic adaptations in Huntington's disease. Curr Opin Neurobiol. 2015;33:53\u201362.","journal-title":"Curr Opin Neurobiol"},{"key":"379_CR27","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.7150\/ijbs.4679","volume":"8","author":"M Erta","year":"2012","unstructured":"Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8:1254\u201366.","journal-title":"Int J Biol Sci"},{"key":"379_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0006-8993(94)91211-4","volume":"637","author":"RA Gadient","year":"1994","unstructured":"Gadient RA, Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res. 1994;637:10\u20134.","journal-title":"Brain Res"},{"key":"379_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0006-8993(01)02013-3","volume":"896","author":"KR Swartz","year":"2001","unstructured":"Swartz KR, Liu F, Sewell D, Schochet T, Campbell I, Sandor M, Fabry Z. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 2001;896:86\u201395.","journal-title":"Brain Res"},{"key":"379_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0014-4886(02)00051-1","volume":"181","author":"M Penkowa","year":"2003","unstructured":"Penkowa M, Giralt M, Lago N, Camats J, Carrasco J, Hernandez J, Molinero A, Campbell IL, Hidalgo J. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol. 2003;181:130\u201348.","journal-title":"Exp Neurol"},{"key":"379_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1471-4159.2002.01131.x","volume":"83","author":"LM Bolin","year":"2002","unstructured":"Bolin LM, Strycharska-Orczyk I, Murray R, Langston JW, Di Monte D. Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. J Neurochem. 2002;83:167\u201375.","journal-title":"J Neurochem"},{"key":"379_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1006\/exnr.1995.1082","volume":"136","author":"Y Akaneya","year":"1995","unstructured":"Akaneya Y, Takahashi M, Hatanaka H. Interleukin-1 beta enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp Neurol. 1995;136:44\u201352.","journal-title":"Exp Neurol"},{"key":"379_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1096\/fj.09-141754","volume":"24","author":"P Chakrabarty","year":"2010","unstructured":"Chakrabarty P, Jansen-West K, Beccard A, Ceballos-Diaz C, Levites Y, Verbeeck C, Zubair AC, Dickson D, Golde TE, Das P. Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2010;24:548\u201359.","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology"},{"key":"379_CR34","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1016\/j.celrep.2017.11.018","volume":"21","author":"LJ Hachigian","year":"2017","unstructured":"Hachigian LJ, Carmona V, Fenster RJ, Kulicke R, Heilbut A, Sittler A. Pereira de Almeida L, Mesirov JP, Gao F, Kolaczyk ED, Heiman M: control of Huntington's disease-associated phenotypes by the striatum-enriched transcription factor Foxp2. Cell Rep. 2017;21:2688\u201395.","journal-title":"Cell Rep"},{"key":"379_CR35","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u20137.","journal-title":"Nucleic Acids Res"},{"key":"379_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma'ayan A. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC bioinformatics. 2013;14:128.","journal-title":"BMC bioinformatics"},{"key":"379_CR37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, et al. Single-cell transcriptomic analysis of Alzheimer's disease. Nature. 2019;570:332\u20137.","journal-title":"Nature"},{"key":"379_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nbt.4091","volume":"36","author":"L Haghverdi","year":"2018","unstructured":"Haghverdi L, Lun ATL, Morgan MD, Marioni JC. Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat Biotechnol. 2018;36:421\u20137.","journal-title":"Nat Biotechnol"},{"key":"379_CR39","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/s41467-018-03933-2","volume":"9","author":"S Mohammadi","year":"2018","unstructured":"Mohammadi S, Ravindra V, Gleich DF, Grama A. A geometric approach to characterize the functional identity of single cells. Nat Commun. 2018;9:1516.","journal-title":"Nat Commun"},{"key":"379_CR40","doi-asserted-by":"crossref","unstructured":"Becht E, Mcinnes L, Healy J, Dutertre CA, Kwok IWH, Ng LG, Ginhoux F, Newell EW: Dimensionality reduction for visualizing single-cell data using UMAP. Nature biotechnology 2018.","DOI":"10.1038\/nbt.4314"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-020-00379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-020-00379-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-020-00379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T19:20:40Z","timestamp":1621797640000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-020-00379-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,24]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["379"],"URL":"https:\/\/doi.org\/10.1186\/s13024-020-00379-3","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,24]]},"assertion":[{"value":"27 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were conducted with the approval of the Massachusetts Institute of Technology Animal Care and Use Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}